GRRMF
Price
$53.55
Change
+$3.09 (+6.12%)
Updated
Jun 25 closing price
Capitalization
4.1B
SAFLF
Price
$0.76
Change
-$0.19 (-20.00%)
Updated
Apr 4 closing price
Capitalization
529.04M
Interact to see
Advertisement

GRRMF vs SAFLF

Header iconGRRMF vs SAFLF Comparison
Open Charts GRRMF vs SAFLFBanner chart's image
Gerresheimer AG
Price$53.55
Change+$3.09 (+6.12%)
Volume$192
Capitalization4.1B
Safilo Group Spa
Price$0.76
Change-$0.19 (-20.00%)
Volume$350
Capitalization529.04M
GRRMF vs SAFLF Comparison Chart in %
Loading...
GRRMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SAFLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GRRMF vs. SAFLF commentary
Jul 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GRRMF is a StrongBuy and SAFLF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 09, 2025
Stock price -- (GRRMF: $53.55 vs. SAFLF: $0.76)
Brand notoriety: GRRMF and SAFLF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: GRRMF: 103% vs. SAFLF: 100%
Market capitalization -- GRRMF: $4.1B vs. SAFLF: $529.04M
GRRMF [@Medical Specialties] is valued at $4.1B. SAFLF’s [@Medical Specialties] market capitalization is $529.04M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GRRMF’s FA Score shows that 0 FA rating(s) are green whileSAFLF’s FA Score has 0 green FA rating(s).

  • GRRMF’s FA Score: 0 green, 5 red.
  • SAFLF’s FA Score: 0 green, 5 red.
According to our system of comparison, both GRRMF and SAFLF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GRRMF’s TA Score shows that 4 TA indicator(s) are bullish while SAFLF’s TA Score has 2 bullish TA indicator(s).

  • GRRMF’s TA Score: 4 bullish, 3 bearish.
  • SAFLF’s TA Score: 2 bullish, 0 bearish.
According to our system of comparison, SAFLF is a better buy in the short-term than GRRMF.

Price Growth

GRRMF (@Medical Specialties) experienced а 0.00% price change this week, while SAFLF (@Medical Specialties) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.28%. For the same industry, the average monthly price growth was +1.39%, and the average quarterly price growth was +0.40%.

Industries' Descriptions

@Medical Specialties (+1.28% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GRRMF($4.1B) has a higher market cap than SAFLF($529M). GRRMF has higher P/E ratio than SAFLF: GRRMF (32.47) vs SAFLF (9.07). SAFLF YTD gains are higher at: -21.993 vs. GRRMF (-23.226). GRRMF has higher annual earnings (EBITDA): 377M vs. SAFLF (127M). GRRMF has more cash in the bank: 133M vs. SAFLF (78.7M). SAFLF has less debt than GRRMF: SAFLF (184M) vs GRRMF (1.11B). GRRMF has higher revenues than SAFLF: GRRMF (1.96B) vs SAFLF (1.03B).
GRRMFSAFLFGRRMF / SAFLF
Capitalization4.1B529M775%
EBITDA377M127M297%
Gain YTD-23.226-21.993106%
P/E Ratio32.479.07358%
Revenue1.96B1.03B190%
Total Cash133M78.7M169%
Total Debt1.11B184M603%
FUNDAMENTALS RATINGS
GRRMF vs SAFLF: Fundamental Ratings
GRRMF
SAFLF
OUTLOOK RATING
1..100
3539
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
63
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8290
PRICE GROWTH RATING
1..100
9180
P/E GROWTH RATING
1..100
87100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GRRMF's Valuation (56) in the null industry is in the same range as SAFLF (63). This means that GRRMF’s stock grew similarly to SAFLF’s over the last 12 months.

GRRMF's Profit vs Risk Rating (100) in the null industry is in the same range as SAFLF (100). This means that GRRMF’s stock grew similarly to SAFLF’s over the last 12 months.

GRRMF's SMR Rating (82) in the null industry is in the same range as SAFLF (90). This means that GRRMF’s stock grew similarly to SAFLF’s over the last 12 months.

SAFLF's Price Growth Rating (80) in the null industry is in the same range as GRRMF (91). This means that SAFLF’s stock grew similarly to GRRMF’s over the last 12 months.

GRRMF's P/E Growth Rating (87) in the null industry is in the same range as SAFLF (100). This means that GRRMF’s stock grew similarly to SAFLF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GRRMFSAFLF
RSI
ODDS (%)
Bullish Trend 2 days ago
25%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
50%
N/A
Momentum
ODDS (%)
Bullish Trend 2 days ago
34%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
43%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
29%
Bullish Trend 2 days ago
25%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
39%
Bullish Trend 2 days ago
19%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
38%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
GRRMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SAFLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PHLOX10.210.07
+0.69%
Philotimo Focused Growth and Income
EMGYX31.20N/A
N/A
Allspring Emerging Markets Equity Adm
MMFYX16.92N/A
N/A
MassMutual Equity Opports Svc
EPLDX22.63N/A
N/A
NYLI Epoch U.S. Equity Yield Class R6
RAFCX41.76-0.02
-0.05%
American Funds AMCAP R3

GRRMF and

Correlation & Price change

A.I.dvisor tells us that GRRMF and SAFLF have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GRRMF and SAFLF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GRRMF
1D Price
Change %
GRRMF100%
N/A
SAFLF - GRRMF
21%
Poorly correlated
N/A
GTHP - GRRMF
6%
Poorly correlated
+5.77%
GNGBY - GRRMF
4%
Poorly correlated
+1.92%
ICCM - GRRMF
3%
Poorly correlated
+9.36%
FZMD - GRRMF
1%
Poorly correlated
N/A
More

SAFLF and

Correlation & Price change

A.I.dvisor tells us that SAFLF and GMED have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SAFLF and GMED's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SAFLF
1D Price
Change %
SAFLF100%
N/A
GMED - SAFLF
28%
Poorly correlated
+1.13%
MYGN - SAFLF
24%
Poorly correlated
+4.91%
JMPHF - SAFLF
23%
Poorly correlated
N/A
OFIX - SAFLF
22%
Poorly correlated
+5.50%
MROPF - SAFLF
21%
Poorly correlated
N/A
More